Daunomycin-induced cardiotoxicity in children and adults
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
A clinicopathologic analysis of adriamycin cardiotoxicity
1973 • 1,534 citations
Statistical Methods in Medical Research
1972 • 620 citations
Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemia
1967 • 470 citations
CARDIAC TOXICITY OF DAUNORUBICIN
1969 • 345 citations
The cardiotoxicity of adriamycin and daunomycin in children
1976 • 168 citations
Chemotherapy of acute lymphocytic leukemia of childhood
1972 • 111 citations
Daunorubicin in the therapy of acute granulocytic leukemia.
1973 • 108 citations
Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).
1973 • 89 citations
Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia
1974 • 83 citations
ACUTE LYMPHOBLASTIC LEUKÆMIA TREATED WITH A COMBINATION OF PREDNISONE, VINCRISTINE, AND RUBIDOMYCIN
1967 • 66 citations
Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.
1971 • 35 citations
Clinical Study of Daunomycin and Prednisone for Induction of Remission in Children with Advanced Leukemia
1969 • 35 citations
Acute leukemia treatment.
1967 • 33 citations
DAUNORUBICIN IN ACUTE MYELOCYTIC LEUKqMIA
1969 • 30 citations
Clinical study of daunomycin (NSC-82151) in children with acute leukemia
1968 • 29 citations
[Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases].
1967 • 24 citations
Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
1968 • 8 citations